Literature DB >> 27770888

Carnauba wax as a promising excipient in melt granulation targeting the preparation of mini-tablets for sustained release of highly soluble drugs.

Viviane Nart1, André O'Reilly Beringhs1, Maria Terezinha França1, Brenda de Espíndola1, Bianca Ramos Pezzini1, Hellen Karine Stulzer2.   

Abstract

Mini-tablets are a new tendency in solid dosage form design for overcoming therapeutic obstacles such as impaired swallowing and polypharmacy therapy. Among their advantages, these systems offer therapeutic benefits such as dose flexibility and combined drug release patterns. The use of lipids in the formulation has also drawn considerable interest as means to modify the drug release from the dosage form. Therefore, this paper aimed at developing sustained release mini-tablets containing the highly soluble drugs captopril and metformin hydrochloride. Carnauba wax was used as a lipid component in melt granulation, targeting the improvement of the drugs poor flowability and tabletability, as well as to sustain the drug release profiles in association with other excipients. To assist sustaining the drug release, Ethocel™ (EC) and Kollicoat® SR 30D associated with Opadry® II were employed as matrix-forming and reservoir-forming materials, respectively. The neat drugs, granules and the bulk formulations were evaluated for their angle of repose, compressibility index, Hausner ratio and tabletability. Mini-tablets were evaluated for their weight variation, hardness, friability, drug content and in-vitro drug release. The results indicated that melt granulation with carnauba wax improved the flow and the tabletability of the drugs, allowing the preparation of mini-tablets with adequate tensile strength under reduced compaction pressures. All mini-tablet formulations showed acceptable hardness (within the range of 1.16 to 3.93Kp) and friability (<0.1%). The melt-granulated captopril in matrix systems containing 50% EC (45P, 100P or 100FP) and the melt-granulated metformin hydrochloride in reservoir systems coated with Kollicoat® SR 30D and Opadry® II (80:20 with 10% weight gain or 70:30 with 20% weight gain) exhibited release profiles adequate to sustained release formulations, for over 450min. Therefore, carnauba wax proved to be a promising excipient in melt granulation targeting the preparation of mini-tablets for sustained release of soluble drugs.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apparatus 3; Carnauba wax; Highly soluble drug; Melt granulation; Mini-tablets; Sustained release

Mesh:

Substances:

Year:  2016        PMID: 27770888     DOI: 10.1016/j.msec.2016.07.070

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  4 in total

Review 1.  Twin-screw extrusion of sustained-release oral dosage forms and medical implants.

Authors:  Xin Feng; Feng Zhang
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

2.  Solid phase wax coating of N-acetylcysteine (NAC) to decrease its solubility profile as a ready to mix supplement.

Authors:  Sara Madarshahian; Mojtaba Enayati; Gerard Vinyes Parés; Gerhard Ufheil; Alireza Abbaspourrad
Journal:  RSC Adv       Date:  2022-06-14       Impact factor: 4.036

3.  Antibody-Functionalized Carnauba Wax Nanoparticles to Target Breast Cancer Cells.

Authors:  Banu Iyisan; Johanna Simon; Yuri Avlasevich; Stanislav Baluschev; Volker Mailaender; Katharina Landfester
Journal:  ACS Appl Bio Mater       Date:  2022-01-03

4.  The Effect of Drug Heterogeneous Distributions within Core-Sheath Nanostructures on Its Sustained Release Profiles.

Authors:  Haixia Xu; Xizi Xu; Siyu Li; Wen-Liang Song; Deng-Guang Yu; S W Annie Bligh
Journal:  Biomolecules       Date:  2021-09-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.